Comparing effects of ramosetron and ondansetron for the prevention of postoperative nausea and vomiting after atrabismus surgery

Ramosetron reduces postoperative nausea after adult strabismus surgery: a prospective, randomized, double-blinded study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000688

Enrollment

240

Registered

2013-02-27

Start date

2011-04-08

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Recruited patients were allocated randomly to receive one of the following three drugs at the end of surgery: intravenous (IV) placebo (normal saline), ondansetron (4 mg), or ramosetron (0.3 mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I and II, and scheduled for strabismus surgery under general anesthesia were enrolled

Exclusion criteria

Exclusion criteria: Patients who took any analgesics, steroids or antiemetics 24 h before surgery, or who had gastrointestinal diseases, previous experience of PONV, or severe motion sickness were excluded.

Design outcomes

Primary

Measure	Time frame
postoperative nausea and vomiting	—

Secondary

Measure	Time frame
adverse effects of ramosetron and ondansetron	—

Countries

Korea, Republic of

Contacts

Public ContactJin Joo

The Catholic University of Korea, Seoul St. Mary's Hospital

jiyo1004@catholic.ac.kr+82-2-2258-6162

Outcome results